NCT05192746

Brief Summary

Extra corporeal shock wave therapy is a treatment method in which high-amplitude sound waves are focused on the targeted body tissue Recently, Extra corporeal shock wave therapy has been proposed as an alternative treatment in patients not responding to pharmaceutical treatment.High power pain threshold ultrasound is the use of therapeutic ultrasound in a continuous mode; with the probe placed directly on affected area (supraspinatus tendon)

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 14, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

January 14, 2022

Status Verified

December 1, 2021

Enrollment Period

9 months

First QC Date

October 27, 2021

Last Update Submit

January 1, 2022

Conditions

Keywords

extracorporeal shock wavehigh power pain threshold ultrasound

Outcome Measures

Primary Outcomes (2)

  • 1. pain intensity[Time Frame:]

    pain will be measured by visual analogue scale higher score mean worse outcome ten centimeter line from zero to ten, zero mean no pain and ten mean maximum pain

    up to four weeks

  • 2.range of motion

    range of motion will be measured by gravititional inclinometer

    up to four weeks

Study Arms (3)

group A "Control group"

EXPERIMENTAL

Twenty two patients will receive conventional treatment hot pack and exercise (control group). .

Other: control group

group B"Extracorporeal shock wave group":

EXPERIMENTAL

Twenty two patients will receive Radial Extra corporeal Shock Wave Therapy plus conventional treatment hot pack and exercise.

Device: extracorporeal shock wave therapy

Group C"High power pain threshold ultrasound group":

EXPERIMENTAL

Twenty two patients will receive High-Power Pain Threshold Ultrasound therapy plus conventional treatment hot pack and exercise

Device: high power pain threshold ultrasound

Interventions

Exercise Therapy and hot pack This tendon exercise program is very effective if done consistently. There are five steps to the program: warm up, stretching exercise, strengthening exercise, stretching exercise, and heat.

group A "Control group"

Shock Master 500 device will be applied once a week for four weeks in total. Each treatment consists of 2000 shocks 3 bar pressure, 20 Hz. Each rESWT session will take about 10 minutes. rESWT application will be performed on the supraspinatus trigger point. In successive treatments, there will be using of an energy density equal to 0.28 mJ/mm2

group B"Extracorporeal shock wave group":

High-power, pain-threshold, ultrasound therapy application (in W/cm2) in continuousmodes, to elicit threshold pain, the ultrasound probe must be kept static on the tendon. Intensity will be gradually increased to the level of maximum pain the patient could bear. It will be kept at that level for 4 to 5 seconds and then will be reduced to the half-intensitylevel for another 15 seconds. This procedure will be repeated 3 times.High-power,

Group C"High power pain threshold ultrasound group":

Eligibility Criteria

Age30 Years - 50 Years
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients' age ranges from 30 to 50 years old.
  • Patients are males and females.
  • BMI of all subjects were \<30 Kg/m2.
  • Patients will be diagnosed as supraspinatus tendinitis.
  • All patients are medically stable.
  • All patients should be conscious and ambulant.
  • Patients don't have any nervous system problems
  • Patients don't have shoulder disorder other than tendenities
  • Patients that didn't undergo any surgery in shoulder joint

You may not qualify if:

  • Patients who received intra articular injection from duration less than 3 months.
  • Patients with supraspinatus tendonitis secondary to trauma.
  • Patients with metal implants.
  • Patient who had malignancy in the affected area.
  • Patient with acute infection in the treated area.
  • Diabetic patients
  • Bone infection
  • Shoulder instability
  • Epilepsy
  • Coagulation diseases
  • Rheumatological diseases (rheumatoid arthritis and gouty arthritis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Control GroupsExtracorporeal Shockwave Therapy

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethodsUltrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: pre post intervention study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

October 27, 2021

First Posted

January 14, 2022

Study Start

January 1, 2022

Primary Completion

October 1, 2022

Study Completion

October 1, 2022

Last Updated

January 14, 2022

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share